Loading content…
Affiliate-supportedIndependent editorialWe never sell medicationSee how
West · California
Local context for Wegovy, Ozempic, Mounjaro, and Zepbound in Fresno (550,000 residents, 1,010,000 metro). Central Valley region has high Medi-Cal enrollment; UCSF Fresno trains a substantial share of local physicians.
Availability and prices vary by pharmacy and date. We do not maintain real-time per-pharmacy stock data. Confirm with pharmacies directly.
Wegovy
semaglutide · Novo Nordisk
Once-weekly semaglutide injection FDA-approved for chronic weight management in adults and adolescents.
Wegovy in Fresno →
Ozempic
semaglutide · Novo Nordisk
Once-weekly semaglutide injection FDA-approved for adults with type 2 diabetes.
Ozempic in Fresno →
Mounjaro
tirzepatide · Eli Lilly
Once-weekly tirzepatide injection FDA-approved for adults with type 2 diabetes.
Mounjaro in Fresno →
Zepbound
tirzepatide · Eli Lilly
Once-weekly tirzepatide injection FDA-approved for chronic weight management and obstructive sleep apnea.
Zepbound in Fresno →
Fresno is a west-region city with a population of 550,000 (1,010,000 in the broader metropolitan area). California expanded Medicaid under the Affordable Care Act, which means low-income adults can typically qualify for GLP-1 coverage for type 2 diabetes if the state Medicaid program lists the drug.
Statewide, notable health systems include Kaiser Permanente, UCSF, Stanford Health, UCLA Health, Cedars-Sinai.
California's Medicaid program is Medi-Cal. Coverage rules for GLP-1 medications vary by drug and indication; see our pricing by state map and payer-coverage guides for details.
Cities of similar size with comparable healthcare markets.